GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2022-04-22 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-21 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-20 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-19 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-18 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-14 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-13 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-12 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-11 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-08 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-07 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-06 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-05 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-04 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-01 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-31 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-30 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-29 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-28 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-25 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-24 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-23 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-22 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-21 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-03-18 $0.000001 $0.000001 $0.000001 $0.000001 0
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT